Pharmaceutical composition for ameliorating lower urinary tract symptoms associated with prostatic hypertrophy

摘要

(R) -5- (2-{[2- (2-ethoxyphenoxy) ethyl] amino} propyl) -2-methoxybenzene-1-sulfonamide (tamsulosin) or a pharmaceutically acceptable salt thereof, and , (1S) -1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid (3R) -quinuclidin-3-yl ester (solifenacin) or a pharmaceutically acceptable salt thereof as an active ingredient And a pharmaceutical composition for improving lower urinary tract symptoms associated with prostatic hypertrophy. In addition, tamsulosin or a pharmaceutically acceptable salt thereof, and a combination of solifenacin or a pharmaceutically acceptable salt thereof and combination therapy for improving lower urinary tract symptoms associated with prostatic hypertrophy are provided.